Showing results (421-430 of 636) with videos related to
Sort By:
Pageof 64
Clinical and Translational Gastroenterology|May 17, 2013
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's MetaplasiaMatteo Fassan, Stefano Volinia, Jeff Palatini, et al.Cancer Gene Therapy|July 24, 2004
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical modelsFrancesco Trapasso, Manuela Sarti, Rossano Cesari, et al.Molecular Oncology|May 15, 2012
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancerClaudia Piovan, Dario Palmieri, Gianpiero Di Leva, et al.Plos One|June 28, 2013
MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung CancerMichela Garofalo, Young-Jun Jeon, Gerard J Nuovo, et al.Cancers|July 16, 2020
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAsTyler Sheetz, Joseph Mills, Anna Tessari, et al.Leukemia|March 13, 2019
Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cellsMarius Bill, Dimitrios Papaioannou, Malith Karunasiri, et al.Oncotarget|January 23, 2016
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRASDanilo Fiore, Elvira Donnarumma, Giuseppina Roscigno, et al.Oncogene|June 26, 2002
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomasMonica Fedele, Sabrina Battista, Lawrence Kenyon, et al.Oncotarget|August 27, 2015
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7Ri Cui, Taewan Kim, Matteo Fassan, et al.Blood|September 1, 2009
Karyotype-specific microRNA signature in chronic lymphocytic leukemiaRosa Visone, Laura Z Rassenti, Angelo Veronese, et al.Pageof 64